Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Paul Ausick | Jun 2, 2018 at 8:35 AM EDT

Procter & Gamble Still the Dow’s Worst-Performing Stock

The worst-performing Dow 30 stock for the year to date remains consumer products giant Procter & Gamble.

Lee Jackson | Jun 1, 2018 at 10:30 AM EDT

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

It’s no surprise that it was only a matter of time before the usage and storage of big data and…

Paul Ausick | May 26, 2018 at 8:55 AM EDT

Procter & Gamble Remains the Dow’s Worst Performing Stock

Procter & Gamble shares added more than 1% last week but that was not enough to allow the consumer products…

Paul Ausick | May 24, 2018 at 4:01 PM EDT

Exxon Mobil, Chevron Clobber the Dow Thursday

Exxon Mobil, Chevron, Johnson & Johnson, and JPMorgan led the Dow to a lower close Thursday.

Paul Ausick | May 19, 2018 at 9:15 AM EDT

Procter & Gamble Now at 5 Weeks as Dow’s Worst Performing Stock

The Dow's worst performing stock for the past 5 weeks has been consumer products giant Procter & Gamble. Last week…

Chris Lange | May 19, 2018 at 8:25 AM EDT

9 Companies Bracing for Big ASCO Reactions

This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.

Paul Ausick | May 18, 2018 at 9:45 AM EDT

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received…

Paul Ausick | May 17, 2018 at 4:01 PM EDT

Walmart, Cisco Weigh on the Dow Thursday

Cisco, Walmart, Merck, and Johnson & Johnson were among the leading losers on the Dow Thursday.

Paul Ausick | May 12, 2018 at 9:10 AM EDT

Procter & Gamble Clings to Ranking as Dow’s Worst Performing Stock

Procter & Gamble was able to add a bit to its share price last week, but not enough for it…

Paul Ausick | May 11, 2018 at 4:01 PM EDT

Merck, Verizon Pace the Dow Friday

The Dow is set to close with a modest gain Friday led by Verizon, Merck, UnitedHealth, and Johnson & Johnson.

Paul Ausick | May 5, 2018 at 8:50 AM EDT

Dow’s Worst Performing Stock Still Procter & Gamble

Procter & Gamble is holding on to its ranking as the worst-performing stock among the 30 equities that comprise the…

Paul Ausick | May 2, 2018 at 4:01 PM EDT

Verizon, McDonald’s Trim the Dow Wednesday

Verizon, Travelers, Johnson & Johnson, and McDonald's weighed on the Dow Wednesday.

Jon C. Ogg | Apr 26, 2018 at 11:05 AM EDT

Johnson & Johnson Commits to Yet Another Dividend Hike

Johnson & Johnson just delivered yet another dividend hike. The company previously had committed to increasing its dividends over and…

Paul Ausick | Apr 21, 2018 at 9:05 AM EDT

Procter & Gamble Sinks, Now Worst-Performing Dow Stock of 2018

Procter & Gamble took over last week as the worst performer among the 30 stocks that comprise the Dow Jones…

Paul Ausick | Apr 18, 2018 at 4:01 PM EDT

IBM, Johnson & Johnson Weigh on the Dow Wednesday

The Dow stocks were split between losers and winners Wednesday with IBM and J&J leading the losers while Home Depot…

1 … 24 25 26 27 28 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Procter & Gamble Still the Dow’s Worst-Performing Stock

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Procter & Gamble Remains the Dow’s Worst Performing Stock

Exxon Mobil, Chevron Clobber the Dow Thursday

Procter & Gamble Now at 5 Weeks as Dow’s Worst Performing Stock

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

Walmart, Cisco Weigh on the Dow Thursday

Procter & Gamble Clings to Ranking as Dow’s Worst Performing Stock

Merck, Verizon Pace the Dow Friday

Dow’s Worst Performing Stock Still Procter & Gamble

Verizon, McDonald’s Trim the Dow Wednesday

Johnson & Johnson Commits to Yet Another Dividend Hike

Procter & Gamble Sinks, Now Worst-Performing Dow Stock of 2018

IBM, Johnson & Johnson Weigh on the Dow Wednesday

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Procter & Gamble Still the Dow’s Worst-Performing Stock

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Procter & Gamble Remains the Dow’s Worst Performing Stock

Exxon Mobil, Chevron Clobber the Dow Thursday

Procter & Gamble Now at 5 Weeks as Dow’s Worst Performing Stock

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

Walmart, Cisco Weigh on the Dow Thursday

Procter & Gamble Clings to Ranking as Dow’s Worst Performing Stock

Merck, Verizon Pace the Dow Friday

Dow’s Worst Performing Stock Still Procter & Gamble

Verizon, McDonald’s Trim the Dow Wednesday

Johnson & Johnson Commits to Yet Another Dividend Hike

Procter & Gamble Sinks, Now Worst-Performing Dow Stock of 2018

IBM, Johnson & Johnson Weigh on the Dow Wednesday

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts